Skip to content

Athena Vanzant, PA-C

NPI 1366568008ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· South Miami, FL

Internal Medicine, Endocrinology, Diabetes & Metabolism (PA-C) in South Miami, Florida, licensed in FL, with an NPI issued in March 2007. Part D covered 2,355 prescriptions written in 2024, 26% of them generic. Novo Nordisk Inc was the largest of 38 companies reporting payments in 2025, $4,390 in all, mostly food and beverage.

Overview

NPI1366568008
StatusActive
Entity typeIndividual
CredentialPA-C
Sole proprietorNo
NPI issuedMar 22, 2007
Last updated in NPPESFeb 6, 2024
Certified by providerFeb 6, 2024

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Physician Assistant (FL)

Part D prescriptions in 2024

Prescriptions (claims)2,355 · 4,955 30-day fills
Patients325
Total drug cost$1,748,527
Generic share26% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$4,390 · 164 payments from 38 companies
  • 2024$3,481 · 164 payments from 28 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$1,05626
Lilly USA, LLC$285.8814
Amgen Inc.$224.0912
Sequel Med Tech, LLC$197.9910
Tandem Diabetes Care, Inc.$178.967

What the 2025 payments were for

  • Food and Beverage$4,390 · 164 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in South Miami

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Florida →